The Vanguard Group 13D and 13G filings for CLOVIS ONCOLOGY INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-09 3:43 pm Sale | 2021-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | The Vanguard Group | 10,115,101 7.780% | -2,179,790 (-17.73%) | Filing |
| 2021-10-12 09:29 am Purchase | 2021-09-30 | 13G | CLOVIS ONCOLOGY INC CLVSQ | The Vanguard Group | 12,294,891 10.380% | 5,907,337 (+92.48%) | Filing |
| 2021-02-10 10:46 am Purchase | 2020-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | The Vanguard Group | 6,387,554 7.230% | 2,169,210 (+51.42%) | Filing |
| 2020-02-12 11:00 am Sale | 2019-12-31 | 13G | CLOVIS ONCOLOGY INC CLVSQ | The Vanguard Group | 4,218,344 7.690% | -1,349,513 (-24.24%) | Filing |